COMP vs JAZZ · rev $5.63B vs P/E 1988, rev $4.07B
Compass Inc (COMP) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Compass Inc (COMP) is a real estate services company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
COMP currently screens at market cap $3.35B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the COMP and JAZZ stock pages for the full models.
Not investment advice.